Company Filing History:
Years Active: 2005-2008
Title: Innovations in HIV Treatment by Inventor Wangni Tian
Introduction
Wangni Tian is a notable inventor based in Jilin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for HIV infection. With a total of 2 patents, his work is paving the way for innovative solutions in healthcare.
Latest Patents
Wangni Tian's latest patents focus on pharmaceutical compositions used for treating HIV infection. One of his inventions is a fusion inhibitor that has a specific amino acid sequence designed to effectively combat HIV. The sequence includes various components, such as an amino group and a hydrophobic group, which enhance its efficacy. Another patent involves a pharmaceutical composition with a peptide sequence that also targets HIV, demonstrating strong inhibitory activity against the virus. These innovations represent a significant advancement in the fight against HIV.
Career Highlights
Wangni Tian is currently associated with Tianjin Fusogen Biotech Co., Ltd., where he continues to develop groundbreaking treatments. His expertise in pharmaceutical sciences has led to the creation of effective therapies that address critical health issues.
Collaborations
Wangni Tian collaborates with Genfa Zhou, contributing to the advancement of their research and development efforts in the biotech industry.
Conclusion
Wangni Tian's innovative work in HIV treatment showcases his dedication to improving healthcare through scientific research. His patents reflect a commitment to finding effective solutions for pressing medical challenges.